FAQ • Education • Posters • Resources • Engage • Supporters • #CPNPcares

Psychiatric and Behavioral Adverse Effects and Complications of Antiseizure Medications

Registration Options

Activity Dates: 04/24/2020 - 04/24/2023

AAPP 2020 registration is closed.

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Antiseizure medications are commonly used to treat a variety of neurological (e.g. epilepsy, epilepsy syndromes, pain, spasticity, migraine headache) and psychiatric conditions (bipolar disorder, aggression, personality disorders). It is well established that antiseizure medication use can be associated with positive or negative psychiatric medication effect(s) depending on the individual medication and patient factors. Patients with epilepsy may also already have a pre-existing psychiatric or neurologic disorder that may be exacerbated by the use of an antiseizure medication. The use of select antiseizure medications is associated with psychiatric and behavioral adverse effects ranging from minor behavioral changes to severe psychiatric complications such as depression, suicidality, and aggression. As antiseizure medications are commonly utilized in clinical practice and, over the past decade, there have been several newly approved medications, it is important to review these adverse effects and potential complications of older and newer antiseizure medications, predictors of these adverse effects, and management strategies to decrease the risk and/or severity of experienced psychiatric and behavioral adverse effects(s) and complication(s).

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Marketa Marvanova, PharmD, PhD, BCGP, BCPP, FASCP

View biographical information and disclosures

Learning Objectives

  1. Discuss common clinical uses of antiseizure medications in neurology and psychiatry.
  2. Identify the major predictors for psychiatric adverse effects and complications of antiseizure medications.
  3. Describe common psychiatric effect(s), positive or negative, associated with select antiseizure medications.
  4. Discuss strategies to enhance tolerability of psychiatric adverse effects.

Continuing Education Credit and Disclosures

Activity Dates: 04/24/2020 - 04/24/2023
ACPE Contact Hours: 1
ACPE Number: 0284-0000-20-036-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.